HKD 3.05
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 4.98 Billion CNY | -9.43% |
2022 | 5.5 Billion CNY | 83.42% |
2021 | 3 Billion CNY | 29.47% |
2020 | 2.31 Billion CNY | 63.4% |
2019 | 1.41 Billion CNY | -1.39% |
2018 | 1.43 Billion HKD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 4.07 Billion CNY | -18.43% |
2024 Q2 | 4.07 Billion CNY | 0.0% |
2023 Q3 | 4.53 Billion CNY | -8.24% |
2023 FY | 4.98 Billion CNY | -9.43% |
2023 Q2 | 4.93 Billion CNY | 7.88% |
2023 Q1 | 4.57 Billion CNY | -16.9% |
2023 Q4 | 4.98 Billion CNY | 10.1% |
2022 Q2 | 4.56 Billion HKD | 0.0% |
2022 Q3 | 4.9 Billion CNY | 7.57% |
2022 Q4 | 5.5 Billion CNY | 12.27% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Life Healthcare Group Limited | 336.13 Million HKD | -1384.471% |
China Biotech Services Holdings Limited | 662.36 Million HKD | -653.336% |